Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Crossover Study in the Treatment of Patients With COPD

ClinicalTrials.gov ID: NCT00462540

Public ClinicalTrials.gov record NCT00462540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 10:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00462540
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dey
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Formoterol Fumurate inhalation solution 20 mcg Drug
  • Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2007
Primary completion
Aug 31, 2007
Completion
Sep 30, 2007
Last update posted
Mar 3, 2009

2007

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Research Site San Diego California 92120
Research Site Denver Colorado 80206
Research Site Wheat Ridge Colorado 80033
Research Site Panama City Florida 32405
Research Site Pensacola Florida 32504
Research Site Coeur d'Alene Idaho 83814
Research Site Sunset Louisiana 70584
Research Site Charlotte North Carolina 28207
Research Site Portland Oregon 97213
Research Site Gaffney South Carolina 29340
Research Site Spartanburg South Carolina 29303
Research Site Johnson City Tennessee 37601
Research Site San Antonio Texas 78205
Research Site Spokane Washington 99204
Research Site Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00462540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2009 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00462540 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →